+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Fluorine-18 Market (Product: FDG, NaF, and Others; and End User: Hospitals, Diagnostic Centers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

  • ID: 5367281
  • Report
  • May 2021
  • Region: Global
  • 174 pages
  • Transparency Market Research

FEATURED COMPANIES

  • Curium Pharma
  • Eli Lilly and Company
  • GE Healthcare
  • Jubilant Pharma Limited
  • Lantheus Holdings, Inc.
  • Siemens Healthineers
  • MORE
This report on the global fluorine-18 market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides the revenue of the global fluorine-18 market for the period of 2017-2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global fluorine-18 market from 2021 to 2031.



The report has been prepared after extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with key industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global fluorine-18 market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global fluorine-18 market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Moreover, the report sheds light on changing competitive dynamics in the global fluorine-18 market. These serve as valuable tools for existing market players as well as entities interested in participating in the global fluorine-18 market.

The report also delves into the competitive landscape of the global fluorine-18 market. Key players operating in the global fluorine-18 market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global fluorine-18 market that have been profiled in this report.

Key Questions Answered in the Report
  • What is the sales/revenue generated by product providers across all regions during the forecast period?
  • What are the opportunities in the global fluorine-18 market?
  • What are the major drivers, restraints, opportunities, and threats in the global market?
  • Which region is set to expand at the fastest CAGR during the forecast period?
  • Which application segment is expected to generate the highest revenue globally in 2030?
  • What are the market positions of different companies operating in the global market?
Fluorine-18 Market - Research Objectives and Research Approach

The comprehensive report on the global fluorine-18 market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of product.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that have been appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global fluorine-18 market in terms of product, end user, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders to make informed business decisions for investment in the global fluorine-18 market.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Curium Pharma
  • Eli Lilly and Company
  • GE Healthcare
  • Jubilant Pharma Limited
  • Lantheus Holdings, Inc.
  • Siemens Healthineers
  • MORE
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Fluorine-18 Market

4. Market Overview
4.1. Introduction & Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Global Fluorine-18 Market Analysis and Forecast, 2017-2031

5. Market Outlook
5.1. Radioactive Material Transport Guidelines
5.2. Radiation Protection Guidelines
5.3. Operating Cost and Pricing Analysis - PET/CT Scan and Fluorine-18 Dose
5.4. Number of PET/CT Scan Installed
5.5. COVID-19 Impact Analysis
5.6. Number of Radiotherapy Centers, by Major Countries
5.7. Pricing Analysis, by Major Brands
5.8. PET Tracers Clinical Trails

6. Global Fluorine-18 Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Global Fluorine-18 Market Value (US$ Mn) Forecast, by Product, 2017-2031
6.2.1. FDG
6.2.2. NaF
6.2.3. Others
6.3. Global Fluorine-18 Market Attractiveness Analysis, by Product

7. Global Fluorine-18 Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Global Fluorine-18 Market Value (US$ Mn) Forecast, by End-user, 2017-2031
7.2.1. Hospitals
7.2.2. Diagnostic Centers
7.2.3. Others
7.3. Global Fluorine-18 Market Attractiveness Analysis, by End-user

8. Global Fluorine-18 Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Global Fluorine-18 Market Value (US$ Mn) Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Fluorine-18 Market Attractiveness Analysis, by Region

9. North America Fluorine-18 Market Analysis and Forecast
9.1. Introduction
9.2. North America Fluorine-18 Market Value (US$ Mn) Forecast, by Product, 2017-2031
9.2.1. FDG
9.2.2. NaF
9.2.3. Others
9.3. North America Fluorine-18 Market Value (US$ Mn) Forecast, by End-user, 2017-2031
9.3.1. Hospitals
9.3.2. Diagnostic Centers
9.3.3. Others
9.4. North America Fluorine-18 Market Value (US$ Mn) Forecast, by Country, 2017-2031
9.4.1. U.S.
9.4.2. Canada
9.5. North America Fluorine-18 Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End-user
9.5.3. By Country

10. Europe Fluorine-18 Market Analysis and Forecast
10.1. Introduction
10.2. Europe Fluorine-18 Market Value (US$ Mn) Forecast, by Product, 2017-2031
10.2.1. FDG
10.2.2. NaF
10.2.3. Others
10.3. Europe Fluorine-18 Market Value (US$ Mn) Forecast, by End-user, 2017-2031
10.3.1. Hospitals
10.3.2. Diagnostic Centers
10.3.3. Others
10.4. Europe Fluorine-18 Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Fluorine-18 Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End-user
10.5.3. By Country/Sub-region

11. Asia Pacific Fluorine-18 Market Analysis and Forecast
11.1. Introduction
11.2. Asia Pacific Fluorine-18 Market Value (US$ Mn) Forecast, by Product, 2017-2031
11.2.1. FDG
11.2.2. NaF
11.2.3. Others
11.3. Asia Pacific Fluorine-18 Market Value (US$ Mn) Forecast, by End-user, 2017-2031
11.3.1. Hospitals
11.3.2. Diagnostic Centers
11.3.3. Others
11.4. Asia Pacific Fluorine-18 Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific Fluorine-18 Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End-user
11.5.3. By Country/Sub-region

12. Latin America Fluorine-18 Market Analysis and Forecast
12.1. Introduction
12.2. Latin America Fluorine-18 Market Value (US$ Mn) Forecast, by Product, 2017-2031
12.2.1. FDG
12.2.2. NaF
12.2.3. Others
12.3. Latin America Fluorine-18 Market Value (US$ Mn) Forecast, by End-user, 2017-2031
12.3.1. Hospitals
12.3.2. Diagnostic Centers
12.3.3. Others
12.4. Latin America Fluorine-18 Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Fluorine-18 Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End-user
12.5.3. By Country/Sub-region

13. Middle East & Africa Fluorine-18 Market Analysis and Forecast
13.1. Introduction
13.2. Middle East & Africa Fluorine-18 Market Value (US$ Mn) Forecast, by Product, 2017-2031
13.2.1. FDG
13.2.2. NaF
13.2.3. Others
13.3. Middle East & Africa Fluorine-18 Market Value (US$ Mn) Forecast, by End-user, 2017-2031
13.3.1. Hospitals
13.3.2. Diagnostic Centers
13.3.3. Others
13.4. Middle East & Africa Fluorine-18 Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Middle East & Africa Fluorine-18 Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By End-user
13.5.3. By Country/Sub-region

14. Competition Landscape
14.1. Market Position Analysis, by Company, 2019
14.2. Company Profiles
14.2.1. Lantheus Holdings, Inc.
14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Growth Strategies
14.2.1.3. SWOT Analysis
14.2.2. Siemens Healthineers
14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.2.2. Growth Strategies
14.2.2.3. SWOT Analysis
14.2.3. Advanced Accelerator Applications (a Novartis AG Company)
14.2.3.1. Company Overview (HQ, Business Segments)
14.2.3.2. Growth Strategies
14.2.3.3. SWOT Analysis
14.2.4. GE Healthcare
14.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.4.2. Growth Strategies
14.2.4.3. SWOT Analysis
14.2.5. Blue Earth Diagnostics (A Bracco Imaging Company)
14.2.5.1. Company Overview (HQ, Business Segments)
14.2.5.2. Growth Strategies
14.2.5.3. SWOT Analysis
14.2.6. Jubilant Pharma Limited
14.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.6.2. Growth Strategies
14.2.6.3. SWOT Analysis
14.2.7. China lsotope & Radiation Corporation
14.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.7.2. Growth Strategies
14.2.7.3. SWOT Analysis
14.2.8. Eli Lilly and Company
14.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.8.2. Growth Strategies
14.2.8.3. SWOT Analysis
14.2.9. Curium Pharma
14.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.9.2. Growth Strategies
14.2.9.3. SWOT Analysis
14.2.10. Yantai Dongcheng Pharmaceutical Group Co., Ltd.
14.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.10.2. Growth Strategies
14.2.10.3. SWOT Analysis

List of Tables
Table 01: North America Installed Base
Table 02: Europe Installed Base
Table 03: Europe Installed Base
Table 04: Asia Pacific and RoW Installed Base
Table 05: Number of Radiotherapy Centers, by Country
Table 06: PET tracers in clinical trials
Table 07: PET tracers in clinical trials
Table 08: PET tracers in clinical trials
Table 09: PET tracers in clinical trials
Table 10: PET tracers in clinical trials
Table 11: PET tracers in clinical trials
Table 12: PET tracers in clinical trials
Table 13: PET tracers in clinical trials
Table 14: Global Fluorine-18 Market Revenue (US$ Mn) Forecast, by Product, 2017-2031
Table 15: Global Fluorine-18 Market Revenue (US$ Mn) Forecast, by End-user, 2017-2031
Table 16: Global Fluorine-18 Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 17: North America Fluorine-18 Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 18: North America Fluorine-18 Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 19: North America Fluorine-18 Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 20: Europe Fluorine-18 Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 21: Europe Fluorine-18 Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 22: Europe Fluorine-18 Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 23: Asia Pacific Fluorine-18 Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 24: Asia Pacific Fluorine-18 Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 25: Asia Pacific Fluorine-18 Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 26: Latin America Fluorine-18 Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 27: Latin America Fluorine-18 Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 28: Latin America Fluorine-18 Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 29: Middle East & Africa Fluorine-18 Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 30: Middle East & Africa Fluorine-18 Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 31: Middle East & Africa Fluorine-18 Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures
Figure 01: Global Fluorine-18 Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 02: Global Fluorine-18 Market Value Share, by Region, 2020
Figure 03: Global Fluorine-18 Market Value Share Analysis, by Product, 2020 and 2031
Figure 04: Global Fluorine-18 Market Revenue (US$ Mn), by FDG, 2017-2031
Figure 05: Global Fluorine-18 Market Revenue (US$ Mn), by NaF, 2017-2031
Figure 06: Global Fluorine-18 Market Revenue (US$ Mn), by Others, 2017-2031
Figure 07: Global Fluorine-18 Market Attractive Analysis, by Product, 2021-2031
Figure 08: Global Fluorine-18 Market Value Share Analysis, by End-user, 2020 and 2031
Figure 09: Global Fluorine-18 Market Revenue (US$ Mn), by Hospitals, 2017-2031
Figure 10: Global Fluorine-18 Market Revenue (US$ Mn), by Diagnostic Centers, 2017-2031
Figure 11: Global Fluorine-18 Market Revenue (US$ Mn), by Others, 2017-2031
Figure 12: Global Fluorine-18 Market Attractive Analysis, by End-user, 2021-2031
Figure 13: Global Fluorine-18 Market Value Share Analysis, by Region, 2020 and 2031
Figure 14: Global Fluorine-18 Market Attractiveness Analysis, by Region, 2021-2031
Figure 15: North America Fluorine-18 Market Value (US$ Mn) Forecast, 2017-2031
Figure 16: North America Fluorine-18 Market Value Share Analysis, by Country, 2020 and 2031
Figure 17: North America Fluorine-18 Market Attractiveness Analysis, by Country, 2021-2031
Figure 18: North America Fluorine-18 Market Value Share Analysis, by Product, 2020 and 2031
Figure 19: North America Fluorine-18 Market Attractiveness Analysis, by Product, 2021-2031
Figure 20: North America Fluorine-18 Market Value Share Analysis, by End-user, 2020 and 2031
Figure 21: North America Fluorine-18 Market Attractiveness Analysis, by End-user, 2021-2031
Figure 22: Europe Fluorine-18 Market Value (US$ Mn) Forecast, 2017-2031
Figure 23: Europe Fluorine-18 Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 24: Europe Fluorine-18 Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
Figure 25: Europe Fluorine-18 Market Value Share Analysis, by Product, 2020 and 2031
Figure 26: Europe Fluorine-18 Market Attractiveness Analysis, by Product, 2021-2031
Figure 27: Europe Fluorine-18 Market Value Share Analysis, by End-user, 2020 and 2031
Figure 28: Europe Fluorine-18 Market Attractiveness Analysis, by End-user, 2021-2031
Figure 29: Asia Pacific Fluorine-18 Market Value (US$ Mn) Forecast, 2017-2031
Figure 30: Asia Pacific Fluorine-18 Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 31: Asia Pacific Fluorine-18 Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
Figure 32: Asia Pacific Fluorine-18 Market Value Share Analysis, by Product, 2020 and 2031
Figure 33: Asia Pacific Fluorine-18 Market Attractiveness Analysis, by Product, 2021-2031
Figure 34: Asia Pacific Fluorine-18 Market Value Share Analysis, by End-user, 2020 and 2031
Figure 35: Asia Pacific Fluorine-18 Market Attractiveness Analysis, by End-user, 2021-2031
Figure 36: Latin America Fluorine-18 Market Value (US$ Mn) Forecast, 2017-2031
Figure 37: Latin America Fluorine-18 Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 38: Latin America Fluorine-18 Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
Figure 39: Latin America Fluorine-18 Market Value Share Analysis, by Product, 2020 and 2031
Figure 40: Latin America Fluorine-18 Market Attractiveness Analysis, by Product, 2021-2031
Figure 41: Latin America Fluorine-18 Market Value Share Analysis, by End-user, 2020 and 2031
Figure 42: Latin America Fluorine-18 Market Attractiveness Analysis, by End-user, 2021-2031
Figure 43: Middle East & Africa Fluorine-18 Market Value (US$ Mn) Forecast, 2017-2031
Figure 44: Middle East & Africa Fluorine-18 Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 45: Middle East & Africa Fluorine-18 Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
Figure 46: Middle East & Africa Fluorine-18 Market Value Share Analysis, by Product, 2020 and 2031
Figure 47: Middle East & Africa Fluorine-18 Market Attractiveness Analysis, by Product, 2021-2031
Figure 48: Middle East & Africa Fluorine-18 Market Value Share Analysis, by End-user, 2020 and 2031
Figure 49: Middle East & Africa Fluorine-18 Market Attractiveness Analysis, by End-user, 2021-2031
Figure 50: Fluorine 18-Market Ranking Analysis
Figure 51: Siemens Healthineers AG Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2020
Figure 52: Siemens Healthineers AG Breakdown of Net Sales (%), by Region, 2020
Figure 53: Siemens Healthineers AG R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017-2020
Figure 54: Siemens Healthineers AG Breakdown of Net Sales (%), by Business Segment, 2020
Figure 55: Lantheus Holdings, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2019
Figure 56: Lantheus Holdings, Inc. Breakdown of Net Sales (%), by Region/Country, 2019
Figure 57: Lantheus Holdings, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017-2020
Figure 58: Jubilant Pharma Limited Revenue (US$ Mn) and Y-o-Y Growth (%), 2018-2020
Figure 59: Jubilant Pharma Limited Breakdown of Net Sales (%), by Region/Country, 2020
Figure 60: Jubilant Pharma Limited Breakdown of Net Sales (%), by Business Segment, 2020
Figure 61: Jubilant Pharma Limited Breakdown of Net Sales (%), by Specialty Pharmaceuticals, 2020
Figure 62: China lsotope & Radiation Corporation - Revenue (US$ Mn) and Y-o-Y Growth (%), 2019-2020
Figure 63: China lsotope & Radiation Corporation - Breakdown of Net Sales (%), by Business Segment, 2020
Figure 64: GE Healthcare Revenue (US$ Mn) and Y-o-Y Growth (%), 2018-2020
Figure 65: GE Healthcare Breakdown of Net Sales (%), by Region/Country, 2020
Figure 66: GE Healthcare Breakdown of Net Sales (%), by Business Segment, 2020
Figure 67: GE Healthcare R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018-2020
Figure 68: Eli Lilly and Company Revenue (US$ Mn) and Y-o-Y Growth (%), 2018-2020
Figure 69: Eli Lilly and Company R&D Intensity - Company Level, 2018-2020
Figure 70: Eli Lilly and Company Breakdown of Net Sales, by Region, 2020
Figure 71: Eli Lilly and Company Breakdown of Net Sales, by Therapeutic Area, 2020
Note: Product cover images may vary from those shown
  • Lantheus Holdings, Inc.
  • Siemens Healthineers
  • Advanced Accelerator Applications (a Novartis AG Company)
  • GE Healthcare
  • Blue Earth Diagnostics (A Bracco Imaging Company)
  • Jubilant Pharma Limited
  • China lsotope & Radiation Corporation
  • Eli Lilly and Company
  • Curium Pharma
  • Yantai Dongcheng Pharmaceutical Group Co., Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll